Analyzing the clinical benefit of newer therapies for advanced or metastatic non-small-cell lung cancer: application of the ESMO-magnitude of clinical benefit scale v1.1
Sign Up to like & getrecommendations! Published in 2021 at "Acta Oncologica"
DOI: 10.1080/0284186x.2021.1942546
Abstract: Abstract Background Despite newer therapies, advanced or metastatic non-small-cell lung cancer (NSCLC) continues to be the leading cause of cancer-related deaths worldwide. Deficits in the design and methods of randomized controlled trials (RCTs) may contribute… read more here.
Keywords: therapies advanced; cancer; oncology; clinical benefit ... See more keywords
Evolving therapies in advanced oesophago-gastric cancers and the increasing role of immunotherapy
Sign Up to like & getrecommendations! Published in 2020 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2021.1866548
Abstract: ABSTRACT Introduction Esophagogastric cancers remain a considerable health burden and among the top causes of global cancer-related deaths. Chemotherapy remains the cornerstone of treatment for patients with advanced disease. Doublet platinum/fluoropyrimidine therapy is established as… read more here.
Keywords: gastric cancers; oesophago gastric; treatment; therapies advanced ... See more keywords
Novel therapies for advanced urologic cancers.
Sign Up to like & getrecommendations! Published in 2020 at "Current Opinion in Urology"
DOI: 10.1097/mou.0000000000000775
Abstract: PURPOSE OF REVIEW Systemic treatment of advanced urogenital malignancies has changed significantly in recent years and it will continue to change rapidly in upcoming years. It is the scope of this review article to providing… read more here.
Keywords: advanced urologic; urologic cancers; therapy; therapies advanced ... See more keywords
Matched therapies for advanced gastric cancer based on genotype: A real-world study in China.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.e16098
Abstract: e16098Background: Systemic therapy options for patients with advanced gastric cancer (GC) are limited. We here presented the efficacy results for advanced GC patients matched to targeted therapies ... read more here.
Keywords: cancer based; therapies advanced; gastric cancer; matched therapies ... See more keywords